Our Mission
Our mission is to develop a platform for early cancer detection using specific biomarkers through liquid biopsies that is accessible to the entire world population, generating social, economic and scientific value.
Our Vision
To contribute with equity in access and quality health care, allowing early cancer diagnosis and improving survival rates and therefore to save lives.
Who we are
Epiliquid is a startup developed in the field of personalized precision medicine, created with the aim of providing solutions to screening, diagnosis and follow-up of cancer patients. Founded in 2021, Epiliquid is the result of a successful partnership between the scientific-academic and private sectors. We have a young, multidisciplinary team work that brings together professionals from science and technological innovation.
Our Team
Emanuel Campoy
Chief Scientific Officer
Responsible for envisioning and building the company scientific strategy and developing evidence to enable the technical validation and clinical utility of the research products.
Clara Garcia Samartino
Chief Technological Officer
Evaluates and sets scientific priorities and coordinates the administrative structure that supports scientists. Responsible for the implementation of the company scientific strategy.
Cintia Vaquer
Senior Scientist
Responsible for technical and pre-clinical validation. Resolves technical conflicts, manages good laboratory practices, and acts as an interlocutor between CTO and junior scientists.
M. Victoria Bocanegra
Chief Medical Officer
Responsible for regulatory affairs and project design based on medical relevance criteria and focused on technological innovation.Develops partnership agreements focusing on collaborative projects.
Rodrigo Militello
Lab Manager
Coordinates with the medical team the correct handling, transport, and storage of biological sample collection to guarantee the highest quality of results. Establishes standard laboratory operating procedures.
Rafael Kemelmajer
Chief Executive Officer
Responsible for fundraising for the next round of investments. Maintains relationships with investors and shareholders. Defines the company's global strategies in areas such as biotechnology and precision medicine.
Marisol Cavichioli
Chief Financial Officer
Responsible for financial planning and management, investment reporting and analysis. Supervises and validates the management control of the group.
Sebastian Arbona
Bioinformatic
Responsible for the development of computer tools to improve the handling of biological data.
Ariel Notcovich
Technical and Scientific advisor
Responsible for providing deep technical and strategic direction. Leads the product vision and innovation strategy.